Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 219

1.

Time-Stratified Case Crossover Study of the Association of Outdoor Ambient Air Pollution With the Risk of Acute Myocardial Infarction in the Context of Seasonal Exposure to the Southeast Asian Haze Problem.

Ho AFW, Zheng H, Earnest A, Cheong KH, Pek PP, Seok JY, Liu N, Kwan YH, Tan JWC, Wong TH, Hausenloy DJ, Foo LL, Tan BYQ, Ong MEH.

J Am Heart Assoc. 2019 Mar 19;8(6):e011272. doi: 10.1161/JAHA.118.011272.

PMID:
31112443
2.

Role of Macrophages in Cardioprotection.

Yap J, Cabrera-Fuentes HA, Irei J, Hausenloy DJ, Boisvert WA.

Int J Mol Sci. 2019 May 19;20(10). pii: E2474. doi: 10.3390/ijms20102474. Review.

PMID:
31109146
3.

Feasibility to Perform T2 * Mapping Postcontrast Administration in Reperfused STEMI Patients for the Detection of Intramyocardial Hemorrhage.

Bulluck H, Chowdhury N, Lim MX, Allen JC, Bryant JA, Chan MY, Chan MHH, Chin CWL, Ho HH, Lim ST, Tan RS, Tan JW, Wong PE, Yeo KK, Cook SA, Hausenloy DJ.

J Magn Reson Imaging. 2019 May 14. doi: 10.1002/jmri.26779. [Epub ahead of print] No abstract available.

PMID:
31087614
4.

Effect of Ischemic Preconditioning and Postconditioning on Exosome-Rich Fraction microRNA Levels, in Relation with Electrophysiological Parameters and Ventricular Arrhythmia in Experimental Closed-Chest Reperfused Myocardial Infarction.

Spannbauer A, Traxler D, Lukovic D, Zlabinger K, Winkler J, Gugerell A, Ferdinandy P, Hausenloy DJ, Pavo N, Emmert MY, Hoerstrup SP, Jakab A, Gyöngyösi M, Riesenhuber M.

Int J Mol Sci. 2019 Apr 30;20(9). pii: E2140. doi: 10.3390/ijms20092140.

5.

Translating Cardioprotection for Patient Benefit: The EU-CARDIOPROTECTION COST Action.

Hausenloy DJ, Heusch G.

J Am Coll Cardiol. 2019 Apr 23;73(15):2001-2003. doi: 10.1016/j.jacc.2019.03.020. No abstract available.

PMID:
31000004
6.

Sex Differences in 1-Year Rehospitalization for Heart Failure and Myocardial Infarction After Primary Percutaneous Coronary Intervention.

Zheng H, Foo LL, Tan HC, Richards AM, Chan SP, Lee CH, Low AFH, Hausenloy DJ, Tan JWC, Sahlen AO, Ho HH, Chai SC, Tong KL, Tan DSY, Yeo KK, Chua TSJ, Lam CSP, Chan MY.

Am J Cardiol. 2019 Jun 15;123(12):1935-1940. doi: 10.1016/j.amjcard.2019.03.021. Epub 2019 Mar 19.

PMID:
30979413
7.

Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial.

Bulluck H, Fröhlich GM, Nicholas JM, Mohdnazri S, Gamma R, Davies J, Sirker A, Mathur A, Blackman D, Garg P, Moon JC, Greenwood JP, Hausenloy DJ.

Am Heart J. 2019 May;211:60-67. doi: 10.1016/j.ahj.2019.02.005. Epub 2019 Feb 20.

8.

Shining the spotlight on cardioprotection: beyond the cardiomyocyte.

Davidson SM, Andreadou I, Garcia-Dorado D, Hausenloy DJ.

Cardiovasc Res. 2019 Mar 13. pii: cvz072. doi: 10.1093/cvr/cvz072. [Epub ahead of print] No abstract available.

PMID:
30865272
9.

Immune cells as targets for cardioprotection: New players and novel therapeutic opportunities.

Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, Liehn E, da CP, Gomes C, Schulz R, Hausenloy DJ.

Cardiovasc Res. 2019 Mar 2. pii: cvz050. doi: 10.1093/cvr/cvz050. [Epub ahead of print]

PMID:
30825305
10.

Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.

Hausenloy DJ, Bøtker HE, Ferdinandy P, Heusch G, Ng GA, Redington A, Garcia-Dorado D.

Cardiovasc Res. 2019 Feb 23. pii: cvz053. doi: 10.1093/cvr/cvz053. [Epub ahead of print]

PMID:
30796814
11.

The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.

Jensen RV, Andreadou I, Hausenloy DJ, Bøtker HE.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E404. doi: 10.3390/ijms20020404. Review.

12.

ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure.

Madonna R, Van Laake LW, Botker HE, Davidson SM, De Caterina R, Engel FB, Eschenhagen T, Fernandez-Aviles F, Hausenloy DJ, Hulot JS, Lecour S, Leor J, Menasché P, Pesce M, Perrino C, Prunier F, Van Linthout S, Ytrehus K, Zimmermann WH, Ferdinandy P, Sluijter JPG.

Cardiovasc Res. 2019 Mar 1;115(3):488-500. doi: 10.1093/cvr/cvz010.

PMID:
30657875
13.

FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.

Yakala GK, Cabrera-Fuentes HA, Crespo-Avilan GE, Rattanasopa C, Burlacu A, George BL, Anand K, Mayan DC, Corlianò M, Hernández-Reséndiz S, Wu Z, Schwerk AMK, Tan ALJ, Trigueros-Motos L, Chèvre R, Chua T, Kleemann R, Liehn EA, Hausenloy DJ, Ghosh S, Singaraja RR.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):387-401. doi: 10.1161/ATVBAHA.118.311903.

PMID:
30651003
14.

Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning.

Cho YJ, Nam K, Kim TK, Choi SW, Kim SJ, Hausenloy DJ, Jeon Y.

Int J Mol Sci. 2019 Jan 11;20(2). pii: E269. doi: 10.3390/ijms20020269.

15.

Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week.

Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225).

J Am Coll Cardiol. 2019 Jan 8;73(1):89-99. doi: 10.1016/j.jacc.2018.09.086. Review.

16.

Coronary Microvascular Injury in Reperfused Acute Myocardial Infarction: A View From an Integrative Perspective.

Sezer M, van Royen N, Umman B, Bugra Z, Bulluck H, Hausenloy DJ, Umman S.

J Am Heart Assoc. 2018 Nov 6;7(21):e009949. doi: 10.1161/JAHA.118.009949. No abstract available.

17.

Air pollution in relation to very short-term risk of ST-segment elevation myocardial infarction: Case-crossover analysis of SWEDEHEART.

Sahlén A, Ljungman P, Erlinge D, Chan MY, Yap J, Hausenloy DJ, Yeo KK, Jernberg T.

Int J Cardiol. 2019 Jan 15;275:26-30. doi: 10.1016/j.ijcard.2018.10.069. Epub 2018 Oct 23.

PMID:
30509372
18.

The coronary circulation in acute myocardial ischaemia/reperfusion injury - a target for cardioprotection.

Hausenloy DJ, Chilian W, Crea F, Davidson SM, Ferdinandy P, Garcia-Dorado D, van Royen N, Schulz R, Heusch G.

Cardiovasc Res. 2018 Nov 14. doi: 10.1093/cvr/cvy286. [Epub ahead of print]

PMID:
30428011
19.

Platelet inhibition to target reperfusion injury trial: Rationale and study design.

Bulluck H, Chan MHH, Bryant JA, Chai P, Chawla A, Chua TS, Chung YC, Fei G, Ho HH, Ho AFW, Hoe AJ, Imran SS, Lee CH, Lim SH, Liew BW, Yun PLZ, Hock MOE, Paradies V, Roe MT, Teo L, Wong AS, Wong E, Wong PE, Watson T, Chan MY, Tan JW, Hausenloy DJ.

Clin Cardiol. 2019 Jan;42(1):5-12. doi: 10.1002/clc.23110. Epub 2018 Dec 17.

20.

Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis.

Bulluck H, Chan MHH, Paradies V, Yellon RL, Ho HH, Chan MY, Chin CWL, Tan JW, Hausenloy DJ.

J Cardiovasc Magn Reson. 2018 Nov 8;20(1):72. doi: 10.1186/s12968-018-0494-3. Review.

Supplemental Content

Loading ...
Support Center